These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 1370648
21. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. Merke J, Milde P, Lewicka S, Hügel U, Klaus G, Mangelsdorf DJ, Haussler MR, Rauterberg EW, Ritz E. J Clin Invest; 1989 Jun; 83(6):1903-15. PubMed ID: 2542376 [Abstract] [Full Text] [Related]
22. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP. Anticancer Res; 1999 Jun; 19(3A):1689-97. PubMed ID: 10470102 [Abstract] [Full Text] [Related]
23. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D. Cancer Res; 1994 Feb 01; 54(3):805-10. PubMed ID: 7508338 [Abstract] [Full Text] [Related]
24. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent. Zhao XY, Ly LH, Peehl DM, Feldman D. Endocrinology; 1997 Aug 01; 138(8):3290-8. PubMed ID: 9231780 [Abstract] [Full Text] [Related]
31. Identification of a competitive binding component in vitamin D-resistant New World primate cells with a low affinity but high capacity for 1,25-dihydroxyvitamin D3. Gacad MA, Adams JS. J Bone Miner Res; 1993 Jan 01; 8(1):27-35. PubMed ID: 8381251 [Abstract] [Full Text] [Related]
33. Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells. Costa EM, Hirst MA, Feldman D. Endocrinology; 1985 Nov 01; 117(5):2203-10. PubMed ID: 2995009 [Abstract] [Full Text] [Related]
35. Effect of a highly potent fluoro analog of 1,25-dihydroxyvitamin D3 on human bone-derived cells. Kiriyama T, Okamoto S, Ejima E, Kurihara N, Hakeda Y, Ito N, Izumi M, Kumegawa M, Nagataki S. Endocrinology; 1991 Jan 01; 128(1):81-6. PubMed ID: 1846118 [Abstract] [Full Text] [Related]
36. 1,25-Dihydroxyvitamin D3 in the Atlantic cod: plasma levels, a plasma binding component, and organ distribution of a high affinity receptor. Sundell K, Bishop JE, Björnsson BT, Norman AW. Endocrinology; 1992 Nov 01; 131(5):2279-86. PubMed ID: 1330497 [Abstract] [Full Text] [Related]
37. Specific cytosol binding proteins for 25(OH)D3 and 1.25(OH)2D3 in human breast cancers. Nakata M, Tsuboi S, Takenaka M, Konishi Y, Kawashima R, Tomita M, Nakagawa T, Iwamura N, Fujita T. Endocrinol Jpn; 1981 Dec 01; 28(6):741-6. PubMed ID: 6286292 [Abstract] [Full Text] [Related]
38. Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor. Koeffler HP, Bishop JE, Reichel H, Singer F, Nagler A, Tobler A, Walka M, Norman AW. Mol Cell Endocrinol; 1990 Mar 26; 70(1):1-11. PubMed ID: 2160380 [Abstract] [Full Text] [Related]